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In nuclear medicine and molecular imaging, positron emission tomography (PET) represents 
a great progress in the clinical development of drugs and diagnostics due to its unique 
capacity to detect, with high sensitivity, ranges of analytes, in vitro or in vivo, that can go 
down to the picomolar scale. This imaging technique greatly relies on the development of 
PROHFXOHVRI LQWHUHVWZKLFK LQFRUSRUDWHDȕ+-emitter element (e.g. 15O, 13N, 11C, 18F…) with 
very short physical half-lives ranging from 2-110 min. Nonetheless, one of the many 
challenges is the timely and effective development of molecules (synthons) that can be 
promptly radiolabeled by appropriately efficient methods. The synthesis of numerous drugs 
and small drug-like compounds with high structural diversity have already shown to benefit 
from convergent multicomponent strategies.1 MCRs also provide a quicker, versatile and 
proficient way to generate vast libraries of small organic molecules from communal 
intermediate backbones, allowing a time-efficient approach to investigate how small changes 
in the overall scaffold may influence functional, biological or pharmacological activity. 
The combination of PET radiolabeling with MCR synthesis of biologically active compounds 
has the potential to greatly simplify radioanalytical and imaging based analyses. It can 
positively influence the design, synthesis and characterization of active compounds, evaluate 
their toxicity, PK/PD properties and ultimately shorten the temporal gap among the different 
clinical trial phases.
Herein, we present a proof of concept study where several structurally different drug-like 
isocyanide-based MCR scaffolds (e.g. arenes ȕ-lactam, tetrazole, oxazole) were 
synthesized to specifically contain a pinacol-derived aryl boronic ester moiety, and used to 
produce their [18F]fluorinated counterparts. These synthons were used since Cu-mediated 
oxidative [18F]fluorination of arylboronic acid pinacol ester derivatives tolerate electron-poor 








In summary, reproducible radiochemical conversion yields from 15% to 76% with short 
reaction times (20 to 30 min.), depending on the scaffolds, were achieved, demonstrating the 
feasibility of the [18F]fluorination of biologically active molecules synthesized via MCR. The 
developed method shows the potential to apply [18F]fluorination in line with MCR and also 
has a latent possibility of incorporating the radiolabeling step in a later stage of this 
convergent “one-pot” synthesis strategy. Finally, a copper(I)-catalyzed [11C]carboxylation of 
the boronic acid esters is also a further perspective, which may expand the variability of 
options beyond fluorine-containing drugs.3
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